CNNA.US Cann American Corp
- Market cap
- USD 1.31M
- P/E
- -
- P/B
- 0.00x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Feb 2023.
Is CNNA.US undervalued?
Graham numberThe Graham number of Cann American Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cann American Corp fundamental analysis
No fundamental analysis for Cann American Corp yet.
Cann American Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cann American Corp
Cann American Corp. is a development stage company dedicated to advancing healthcare solutions through innovative therapies. The company focuses on making healthcare affordable and accessible. By leveraging cutting-edge technology, the company aims to reduce costs and improve the availability of high-quality healthcare services for all patients. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Co…
Full company profileCann American Corp financial statements
Cann American Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2018 | 2019 | 2020 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 25.62 | 116.65 | 26.10 | - | - |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.09 | 87.52 | 16.71 | - | - |
| Operating Income | -12.3K | -45.2K | -258K | -780K | -143K | -0.50 | -7.49 | -14.08 | -198.00 | -145.00 |
| EBITDA | -12.3K | -45.2K | -258K | - | - | 0.17 | -3.49 | -8.09 | 0.76 | -114.40 |
| Net Income | -12.4K | -45.4K | -265K | -1.37M | -173K | -0.50 | -7.49 | -249.00 | 10.5K | 3.82K |
| EPS | -3.83 | -14 | -110 | - | - | 0.00 | 0.00 | 0.00 | 0.04 | 0.01 |
| Balance Sheet | ||||||||||
| Total Assets | 96.00 | 1.20M | 1.19M | 917K | 917K | 199.50 | 194.88 | 47.15 | 205.56 | 65.19 |
| Total Liabilities | 13.5K | 68.8K | 244K | 407K | 384K | 200.00 | 202.87 | 4.16 | 6.85K | 2.88K |
| Shareholders' Equity | -13.4K | 1.13M | 948K | 511K | 534K | -0.50 | -7.99 | 42.99 | -6.65K | -2.81K |
| Cash & Short-term Investments | 96.00 | 59.00 | 191.00 | 285.00 | 285.00 | 2.43 | 1.81 | 45.81 | 200.56 | 48.39 |
| Total Debt | - | 60.5K | 64.5K | - | - | 200.00 | 200.00 | 2.00 | 402.40 | 359.47 |
| Cash Flow | ||||||||||
| Operating Cash Flow | -8.94K | -49.5K | -53.9K | -333K | -31.7K | 0.17 | -0.62 | -244.00 | -342.00 | 5.02 |
| Capital Expenditure | 500.00 | 500.00 | 12.0K | 0.00 | 0.00 | 12.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -9.44K | -50.0K | -53.9K | - | - | -11.84 | -0.62 | -244.00 | -342.00 | 5.02 |
| Ratios | ||||||||||
| ROE | - | -4.0% | -27.9% | -269.1% | -32.3% | - | - | -579.2% | - | - |
| ROA | -12,959.4% | -3.8% | -22.2% | -149.8% | -18.8% | -0.3% | -3.8% | -528.1% | 5,127.9% | 5,861.3% |
| Net Profit Margin | - | - | - | - | - | -2.0% | -6.4% | -954.0% | - | - |
| Debt to Equity | - | 0.05x | 0.07x | - | - | - | - | 0.05x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cann American Corp dividends
Cann American Corp has not paid dividends in the last 10 fiscal years.
Last stock split: 1:10 on Nov 13, 2020.
Who owns Cann American Corp
- Insiders 9.53%
- Institutions 0.00%
- Public & others 90.47%
- Shares outstanding 262M
Cann American Corp company profile
- Company name
- Cann American Corp
- Ticker
- CNNA.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 1
- Fiscal year end
- February
- Address
- 121 South Orange Avenue, Orlando, FL, United States, 32801
- Phone
- 888 722 1247
- Website
- cnnacorp.com
About Cann American Corp
Cann American Corp. is a development stage company dedicated to advancing healthcare solutions through innovative therapies. The company focuses on making healthcare affordable and accessible. By leveraging cutting-edge technology, the company aims to reduce costs and improve the availability of high-quality healthcare services for all patients. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was established in 2004 and is headquartered in Orlando, Florida.
Cann American Corp management
2- Mr. Jason R. TuckerCFO, CEO, Secretary, Treasurer & Director · born 1977
- Mr. Michael G. KramerPresident, COO and Director · born 1979